Menu Search
Equities

Core Laboratories Inc

CLB*:MEX

Core Laboratories Inc

Actions
  • Price (MXN)856.38
  • Today's Change0.00 / 0.00%
  • Shares traded-1.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Dec 18 2019 11:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. In addition, the Company assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. The Company has two segments. Reservoir Description segment provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry. In addition, it provides reservoir description capabilities. Production Enhancement segment provides integrated diagnostic services. The Company has approximately 70 offices in more than 50 countries.

  • Revenue in USD (TTM)511.07m
  • Net income in USD37.52m
  • Incorporated2023
  • Employees3.60k
  • Location
    Core Laboratories Inc6316 Windfern RoadHOUSTON 77040United StatesUSA
  • Phone+1 (713) 328-2673
  • Fax+1 (302) 655-5049
  • Websitehttps://www.corelab.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.